management will participate at the 24th Annual
management will provide an overview of the company followed by a
question and answer period with investors.
A live webcast of the presentation will be accessible through the
Investors section of the Company’s website at www.amagpharma.com.
Following the conference, the webcast will be archived on the
development and commercialization of a therapeutic iron compound to
treat iron deficiency anemia. For additional company information, please
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303